Safety, tolerability, pharmacokinetics, and pharmacodynamics of a TLR7 agonist prodrug RO6870868 in healthy volunteers

por Grippo, Joseph F., Folitar, Ilia, Passe, Sharon, Jiang, Qiudi, Rodriguez, Ignacio, Fettner, Scott H., Calleja, Elizabeth
Publicado 2021

PReS-FINAL-2159: Tocilizumab (TCZ) dosing in juvenile idiopathic arthritis (JIA): optimising for different JIA type and body weight patients

por Lu, P, Hsu, J, Keane, C, Fettner, S, Wang, J, Ruperto, N, Harari, O, Brunner, HI, De Benedetti, F
Publicado 2013

Pharmacokinetic and Pharmacodynamic Analysis of Subcutaneous Tocilizumab in Patients With Rheumatoid Arthritis From 2 Randomized, Controlled Trials: SUMMACTA and BREVACTA

por Abdallah, Hisham, Hsu, Joy C., Lu, Peng, Fettner, Scott, Zhang, Xiaoping, Douglass, Wendy, Bao, Min, Rowell, Lucy, Burmester, Gerd R., Kivitz, Alan
Publicado 2016

Safety and Pharmacokinetic Characterization of Nacubactam, a Novel β-Lactamase Inhibitor, Alone and in Combination with Meropenem, in Healthy Volunteers

por Mallalieu, Navita L., Winter, Erica, Fettner, Scott, Patel, Katie, Zwanziger, Elke, Attley, Gemma, Rodriguez, Ignacio, Kano, Akiko, Salama, Sameeh M., Bentley, Darren, Geretti, Anna Maria
Publicado 2020